PAPA-1 is a nuclear binding partner of IGFBP-2 and modulates its growth-promoting actions

Molecular Endocrinology

Volumn 23, Issue 2, 2009, Pages 169-175

  Miyako, Kenichi ^a   Cobb, Laura J ^a,b,c   Francis, Malik ^a   Huang, Alden ^a   Peng, Bonnie ^b   Pintar, John E ^b   Ariga, Hiroyoshi ^c   Cohen, Pinchas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; GLUTATHIONE TRANSFERASE; PROTEIN KINASE PIM 1; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN;

ARTICLE; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ASSAY; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; ONCOGENE MYC; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION;

ANIMALS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; MALE; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; PROSTATE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-PIM-1; RNA, SMALL INTERFERING; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 58849109117     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0168     Document Type: Article

References (34)

1. Wetterau LA, Moore MG, Lee KW, Shim ML, Cohen P 1999 Novel aspects of the insulin-like growth factor binding proteins. Mol Genet Metab 68:161-181
2. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
3. Ho PJ, Baxter RC 1997 Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol(Oxf) 46:333-342
4. Cohen P, Peehl DM, Stamey TA, Wilson KF, Clemmons DR, Rosenfeld RG 1993 Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab 76:1031-1035
5. Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS 1997 Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IG-FBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J Clin Endocrinol Metab 82:2308-2313
6. el Atiq F, Garrouste F, Remacle-Bonnet M, Sastre B, Pommier G 1994 Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer. Int J Cancer 57:491-497
7. MullerHL, OhY, Lehrnbecher T, Blum WF, Rosenfeld RG 1994 Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J Clin Endocrinol Metab 79:428 -434
8. Lee EJ, Mircean C, Shmulevich I, Wang H, Liu J, Niemisto A, Kavanagh JJ, Lee JH, Zhang W 2005 Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer 4:7
9. Shi LH, Zhu XQ, Zhao GH, Xia YB, Zhang YS 2006 Expression of insulinlike growth factor binding protein-2 in gastric carcinoma and its relationship with cell proliferation. World J Gastroenterol 12:6285-6289
10. Kiyama S, Morrison K, Zellweger T, Akbari M, Cox M, Yu D, Miyake H, Gleave ME 2003 Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors. Cancer Res 63:3575-3584
11. Schutt BS, Langkamp M, Rauschnabel U, Ranke MB, Elmlinger MW 2004 Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. J Mol Endocrinol 32:859-868
12. Wang GK, Hu L, Fuller GN, Zhang W 2006 An interaction between insulinlike growth factor-binding protein 2 (IGFBP2) and integrin α5 is essential for IGFBP2-induced cell mobility. J Biol Chem 281:14085-14091
13. Pereira JJ, Meyer T, Docherty SE, Reid HH, Marshall J, Thompson EW, Rossjohn J, Price JT 2004 Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with αvβ3 negatively modulates IGF-I-mediated migration and tumor growth. Cancer Res 64:977-984
14. Moore MG, Wetterau LA, Francis MJ, Peehl DM, Cohen P 2003 Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells. Int J Cancer 105:14-19
15. Mehrian-Shai R, Chen CD, Shi T, Horvath S, Nelson SF, Reichardt JK, Sawyers CL 2007 Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer. Proc Natl Acad Sci USA 104:5563-5568
16. Perks CM, VernonEG, Rosendahl AH, Tonge D, Holly JM 2007 IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells. Oncogene 26:5966-5972
17. Hettmer S, Dannecker L, Foell J, Elmlinger MW, Dannecker GE 2005 Effects of insulin-like growth factors and insulin-like growth factor binding protein-2 on the in vitro proliferation of peripheral blood mononuclear cells. Hum Immunol 66:95-103
18. Shi Z, Henwood MJ, Bannerman P, Batista D, Horvath A, Guttenberg M, Stratakis CA, Grimberg A 2007 Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A. Growth Horm IGF Res 17:113-121
19. Chatterjee S, Park ES, Soloff MS 2004 Proliferation of DU145 prostate cancer cells is inhibited by suppressing insulin-like growth factor binding protein-2. Int JUrol 11:876-884
20. Fukushima T, Tezuka T, Shimomura T, Nakano S, Kataoka H 2007 Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24. J Biol Chem 282:18634-18644
21. Dunlap SM, Celestino J, Wang H, Jiang R, Holland EC, Fuller GN, Zhang W 2007 Insulin-like growth factor binding protein 2 promotes glioma development and progression. Proc Natl Acad Sci USA 104:11736-11741
22. Frommer KW, Reichenmiller K, Schutt BS, Hoeflich A, Ranke MB, Dodt G, Elmlinger MW 2006 IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. JMol Endocrinol 37:13-23
23. Terrien X, Bonvin E, Corroyer S, Tabary O, Clement A, Henrion Caude A 2005 Intracellular colocalization and interaction of IGF-binding protein-2 with the cyclin-dependent kinase inhibitor p21CIP1/WAF1 during growth inhibition. Biochem J392:457-465
24. Hoeflich A, Reisinger R, Schuett BS, Elmlinger MW, Russo VC, Vargas GA, Jehle PM, Lahm H, Renner-Muller I, Wolf E 2004 Peri/nuclear localization of intact insulin-like growth factor binding protein-2 and a distinct carboxyl-termi-nal IGFBP-2 fragment in vivo. Biochem Biophys Res Commun 324:705-710
25. Besnard V, Corroyer S, Trugnan G, Chadelat K, Nabeyrat E, Cazals V, Clement A 2001 Distinct patterns of insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-3 expression in oxidant exposed lung epithelial cells. Biochim Biophys Acta 1538:47-58
26. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P 2000 Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-α regulate transcriptional signaling and apoptosis. J Biol Chem 275:33607-33613
27. Wood TL, Rogler LE, Czick ME, Schuller AG, Pintar JE 2000 Selective alterations in organ sizes in mice with a targeted disruption of the insulinlike growth factor binding protein-2 gene. Mol Endocrinol 14:1472-1482
28. Demambro VE, Clemmons DR, Horton LG, Bouxsein ML, Wood TL, Beamer WG, Canalis E, Rosen CJ 2008 Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. Endocrinology 149:2051-2061
29. Kuroda TS, Maita H, Tabata T, Taira T, Kitaura H, Ariga H, Iguchi-Ariga SM 2004 A novel nucleolar protein, PAPA-1, induces growth arrest as a result of cell cycle arrest at the G1 phase. Gene 340:83-98
30. Maita H, Harada Y, Nagakubo D, Kitaura H, Ikeda M, Tamai K, Takahashi K, Ariga H, Iguchi-Ariga SM 2000 PAP-1, a novel target protein of phosphorylation by pim-1 kinase. Eur J Biochem 267:5168-5178
31. Schedlich LJ, Le Page SL, Firth SM, Briggs LJ, Jans DA, Baxter RC 2000 Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin β-subunit. J Biol Chem 275:23462-23470
32. Schedlich LJ, Young TF, Firth SM, Baxter RC 1998 Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 273:18347-18352
33. Christophe D, Christophe-Hobertus C, Pichon B 2000 Nuclear targeting of proteins: how many different signals? Cell Signal 12:337-341
34. SongSW,FullerGN,KhanA,KongS,ShenW,TaylorE,RamdasL,LangFF, Zhang W 2003 IIp45, an insulin-like growth factor binding protein 2 (IG-FBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc Natl Acad Sci USA 100:13970-13975